Furthermore, PLEX replaces deficient or mutated circulating ADAMTS13 and complement regulators, thereby addressing multiple potential mechanisms underlying TMA in SLE patients [20]. The gene discussed is ADAMTS13; the disease is systemic lupus erythematosus.